NIH Tetramer Core Facility

The Department of Health and Human Services, National Institute of Health, National Institute of Allergy and Infectious Diseases has a continuing requirement for contractor to support the Tetramer Core Facility.

Solicitation Summary

The Department of Health and Human Services, National Institute of Health, National Institute of Allergy and Infectious Diseases has a continuing requirement for contractor to support the Tetramer Core Facility.

Solicitation in a Nutshell

Item

Details

Agency Department of Health and Human Services, National Institute of Health, National Institute of Allergy and Infectious Diseases
Solicitation Number SBSS75N93026R00006
Status Pre-RFP
Solicitation Date 07/2026 (Estimate)
Award Date 03/2027 (Estimate)
Contract Ceiling Value $50,000,000
Competition Type  Full and Open / Unrestricted
Type of Award  IDIQ – Agency Specific
Primary Requirement  Research & Development
Duration  7 year(s) base
Contract Type  Indefinite Delivery Indefinite Quantity
No. of Expected Awards N/A
NAICS Code(s):
541714

Research and Development in Biotechnology (except Nanobiotechnology)
Size Standard: 1000 Employees

Place of Performance:
  • United States
    • CONTRACTOR’S FACILITY
Opportunity Website: https://sam.gov/opp/c521902dbb654fc7ad24ea644282f95f/view

Background

As a part of the research program to improve our understanding of the progression, prevention, and treatment of infectious and immune-mediated diseases, the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) is competing the continuing requirement for the NIH Major Histocompatibility Complex (MHC) Tetramer Core Facility contract (herein referred to as the NIH Tetramer Core Facility). This facility provides synthesis and distribution of soluble MHC tetramer reagents to the global research community.

Requirements

  • The scope of activities to be carried out by the NIH Tetramer Core Facility Contractor are synthesis and distribution of soluble MHC-peptide tetramers and related reagents to the broader scientific community. Such reagents include, but are not limited to: mouse, nonhuman primate, human, and other mammalian MHC class I monomers and tetramers; custom and premade mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer detection
  • The major functions to be carried out by the contractor are:
    • Provide a tetramer production facility
    • Provide a distribution, tracking, and reporting system for reagents produced
    • Design a NIH Tetramer Core Facility website and provide related maintenance
    • Provide Tetramer Core Facility program management

How can GDIC Help?

As a consulting firm that specializes in helping companies prepare winning proposals for government contracts, GDIC can provide a wide range of services to help offerors prepare their C2E proposal, including capture management, proposal writing, proposal management, and proposal review. GDIC can also provide training and support to help offerors understand the technical and administrative requirements outlined in the solicitation, and can provide guidance on how to structure the proposal to maximize its chances of success.

Our business development and proposal professionals have several decades of experience and expertise in construction proposals and contracts for government. By working with GDIC, offerors can increase their chances of winning the C2E contract and can position themselves for long-term success in the federal marketplace.